Business Wire

Global Meningitis Imaging Market Forecast Report to 2027 – Market Growth of 4.3% CAGR During 2021-2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Meningitis Imaging Market By Product Type, By Disease Type, By End User, By Regional Outlook, Industry Analysis Report and Forecast, 2021-2027” report has been added to ResearchAndMarkets.com’s offering.

The Global Meningitis Imaging Market size is expected to reach $223.7 thousands by 2027, rising at a market growth of 4.3% CAGR during the forecast period.

Factors like increased prevalence of meningitis disease; rise in various types of meningitis such as bacterial meningitis, viral meningitis, and fungal meningitis; surge in cases of tuberculosis that causes bacterial meningitis; surge in usage of computed tomography scans to determine the infection are estimated to fuel the growth of the meningitis imaging market. In addition, there is a rise in demand for magnetic resonance imaging, positron emission tomography, and computed tomography scans to detect infection.

COVID-19 Impact Analysis

The COVID-19 outbreak is expected to have a positive impact on the worldwide meningitis imaging market. In the initial stage of the pandemic, a few cases of meningitis and covid-19 infection were reported simultaneously. In that instance, computed tomography and magnetic resonance imaging are the most effective instruments for identifying the infection and monitoring the treatment’s success. There are many patients who went for meningitis imaging to determine the level of effects caused by the virus.

The therapeutic utility of CT was increased by implementing suitable preventative safety measures, optimizing chest CT protocols, and building a uniform reporting system based on pulmonary results in this condition. As a result of the increase of Covid-19 cases, the use of computed tomography scans is expected to drive the meningitis imaging market over the forecast period.

Market Growth Factors:

  • Rising cases of HIV and other infectious diseases: There is a rise in the cases of various infectious diseases and HIV, which creates more demand for meningitis imaging. As per the World Health Organization (WHO), approximately 38 million individuals are infected with HIV in 2020, which is increasing the cases of meningitis among people. HIV targets the immune system by killing CD4+ T cells, a kind of white blood cell that is essential for infection resistance. People infected with HIV are more susceptible to various infections, illnesses, and meningitis.
  • Growing investment on R&D activities by healthcare vendors and governments: The prevalence of various diseases across the globe is motivating governments to invest a significant amount in R&D activities. Several healthcare vendors are increasing their investment in R&D to develop more advanced meningitis imaging devices and tools. In addition, governments are trying to make the healthcare facilities more accessible and inexpensive so that any person can be tested and receive proper treatment for the tested disease.

Marketing Restraining Factors:

  • Lack of skilled professionals: Since technologies and procedures used for meningitis imaging are highly technical, personnel who are using these technologies and devices need to be well-aware of their usage. Having sound knowledge of the machine and its operations is important to make full use of these devices. However, a lack of this knowledge can lead to severe problems. People operating CT and MRI machines need to get proper formal training to operate the machines in order to produce accurate results.

Regional Outlook

Region-wise, the meningitis imaging market is analyzed across North America, Europe, Asia Pacific and LAMEA. North America dominated the meningitis imaging market in 2020 and is expected to continue to do so during the forecast period. This growth is attributed to the rising prevalence of inflammatory diseases, the presence of key players, the development of the healthcare sector, the presence of new innovative imaging systems, and advancements in computed tomography technology.

Market Segments Covered in the Report:

By Product Type

  • Computer Tomography (CT)
  • Magnetic Resonance Imaging (MRI) and
  • Positron Emission Tomography

By Disease Type

  • Viral Meningitis
  • Fungal Meningitis
  • Bacterial Meningitis and
  • Others

By End User

  • Hospitals & Clinics and
  • Diagnostic Centers

List of Companies Profiled in the Report:

  • Shimadzu Corporation
  • Accuray, Incorporated
  • United Imaging Healthcare Co., Ltd.
  • Positron Corporation
  • Neusoft Medical Systems Co., Ltd.
  • Siemens AG
  • Fujifilm Holdings Corporation
  • General Electric (GE) Co.
  • Koninklijke Philips N.V.
  • Canon, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/u55pi9

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button